Use of Systemic Rosmarinus Officinalis to Enhance the Survival of Random-Pattern Skin Flaps

Yıl 2016, Cilt: 33 Sayı: 6, 645 - 651, 01.11.2016

Bilsev İnce Fatma Bilgen Ayşe Özlem Gündeşlioğlu Mehmet Dadacı Sümeyye Kozacıoğlu

Öz

Background: Skin flaps are commonly used in soft-tissue reconstruction; however, necrosis can be a frequent complication. Several systemic and local agents have been used in attempts to improve skin flap survival, but none that can prevent flap necrosis have been identified.  Aims: This study aims to determine whether the use of systemic Rosmarinus officinalis (R. officinalis) extract can prevent flap necrosis and improve skin flap recovery.  Study Design: Animal experimentation.  Methods: Thirty-five Wistar albino rats were divided in five groups. A rectangular random-pattern flaps measuring 8×2 cm was elevated from the back of each rat. Group I was the control group. In Group II, 0.2 ml of R. officinalis oil was given orally 2h before surgery. R. officinalis oil was then applied orally twice a day for a week. In Group III, R. officinalis oil was given orally twice a day for one week before surgery. At the end of the week, 0.2 mL of R. officinalis oil was given orally 2 h before surgery. In Group IV, 0.2 mL of R. officinalis oil was injected subcutaneously 2 h before surgery. After the surgery, 0.2 mL R. officinalis oil was injected subcutaneously twice a day for one week. In Group V, 0.2 mL R. officinalis oil was injected subcutaneously twice a day for one week prior to surgery. At the end of the week, one last 0.2 mL  R. officinalis oil injection was administered subcutaneously 2 h before surgery. After the surgery, 0.2 mL R. officinalis oil was injected subcutaneously twice a day for one week.  Results: The mean percentage of viable surface area was significantly greater (p<0.05) in Groups II, III, IV, and V as compared to Group I. Mean vessel diameter was significantly greater (p<0.05) in Groups II, III, IV, and V as compared to Group I. Conclusion: We have determined that, in addition to its anti-inflammatory and anti-oxidant effects, R. officinalis has vasodilatory effects that contribute to increased skin flap survival.

Anahtar Kelimeler

Rosmarinus officinalis, flap survivability, tissue defect, rosemary

Kaynakça

• 1. Smith JD, Pribaz JJ. Flaps. In: Plastic surgery indications, operations and outcomes. Achauer BM, Eriksson E, Wilkins EG, Vandekam VM editors. 2nd ed. St. Louis-Missouri: Mosby, 2000; 1: 261-90.
• 2. Karacaoglu E, Yuksel F, Turan SO, Zienowicz RJ. Chemical delay: an alternative to surgical delay experimental study. Ann Plast Surg 2002;49:73-80. [CrossRef]
• 3. Kose R, Yildirim AM, Okur MI, Tugrul I. The effects of Nω-nitro -L-arginine (L-NNA) on blood pressure and survival of the skin flaps in rats. Turk Plast Surg 2010;18:6- 10.
• 4. Demirel M, Heper AO, Yormuk E. Comparison of pharmacologic delay operation by local VEGF injection with other surgical delay procedures on rat dorsal skin flap. Turk Plast Surg 2010;18:24-30.
• 5. Ince B, Yildirim AM, Okur MI, Dadaci M, Yoruk E. Effects of Rosmarinus officinalis on the survivability of random-patterned skin flaps: an experimental study. J Plast Surg Hand Surg 2015;49:83-7. [CrossRef]
• 6. Angioni A, Barra A, Cereti E, Barile D, Coïsson JD, Arlorio M, et al. Chemical composition, plant genetic differences, antimicrobial and antifungal activity investigation of the essential oil of Rosmarinus officinalis L. J Agric Food Chem 2004;52:3530- 5. [CrossRef]
• 7. Bozin B, Mimica N, Samojlik I, Jovin E. Antimicrobial and antioxidant properties of rosemary and sage (Rosmarinus officinalis L. and Salvia officinalis L, Lamiaceae) essential oils. J Agric Food Chem 2007;55:7879-85. [CrossRef
• 8. Fu Y, Zu Y, Chen L, Efferth T, Liang H, Liu Z. Investigation of antibacterial activity of rosemary essential oil against Propionibacterium acnes with atomic force microscopy. Planta Med 2007:1275-80. [CrossRef]
• 9. Luqman S, Dwivedi GR, Darokar MP, Kalra A, Khanuja SP. Potential of rosemary oil to be used in drug-resistant infections. Altern Ther Health Med 2007;13:54-9.
• 10. van Vuuren SF, Suliman S, Viljoen AM. The antimicrobial activity of four commercial essential oils in combination with conventional antimicrobials. Lett Appl Microbiol 2009;48:440-6. [CrossRef]
• 11. Siurin SA. Effects of essential oil on lipid peroxidation and lipid metabolism in patients with chronic bronchitis. Klin Med (Mosk) 1997;75:43-5.
• 12. Bhale SD, Xu Z, Prinyawiwatkul W, King JM, Godber JS. Oregano and rosemary extracts inhibit oxidation of long-chain n-3 fatty acids in menhaden oil. J Food Sci 2007;72:504-8. [CrossRef]
• 13. Huang HC, Huang CY, Lin-Shiau SY, Lin JK. Ursolic acid inhibits IL-1beta or TNF-alpha-induced C6 glioma invasion through suppressing the association ZIP/p62 with PKC-zeta and downregulating the MMP-9 expression. Mol Carcinog 2009;48:517- 31. [CrossRef]
• 14. Posadas SJ, Caz V, Largo C, De la Gándara B, Matallanas B, Reglero G, et al. Protective effect of supercritical fluid rosemary extract, Rosmarinus officinalis, on antioxidants of major organs of aged rats. Exp Gerontol 2009;44:383-9. [CrossRef]
• 15. Bakirel T, Bakirel U, Keles OU, Ulgen SG, Yardibi H. In vivo assessment of antidiyabetic and antioxidant activities of rosemary (Rosmarinus Officinalis) in alloxan-diyabetic rabbits. J Ethnopharmacol 2008;116:64-73. [CrossRef]
• 16. Cheung S, Tai J. Anti-proliferative and antioxidant properties of rosemary Rosmarinus officinalis. Oncol Rep 2007;17:1525-31. [CrossRef]
• 17. Almela L, Sánchez MB, Fernández JA, Roca MJ, Rabe V. Liquid chromatograpic-mass spectrometric analysis of phenolics and free radical scavenging activity of rosemary extract from different raw material. J Chromatogr A 2006;1120:221-9. [CrossRef]
• 18. D’Evoli L, Huikko L, Lampi AM, Lucarini M, Lombardi-Boccia G, Nicoli S, et al. Influence of rosemary (Rosmarinus officinalis, L.) on plant sterol oxidation in extra virgin olive oil. Mol Nutr Food Res 2006;50:818-23. [CrossRef]